Open AccessRhabdomyolysis and coronavirus disease‐2019 in children: A case report and review of the literature
Author(s) -
Kontou Maria,
Kakleas Konstantinos,
Kimioni Vaso,
Georgiadi Dimitra,
Spoulou Vasiliki,
Michos Athanasios
Publication year - 2022
Publication title -
pediatric investigation
Language(s) - English
Resource type - Journals
ISSN - 2574-2272
DOI - 10.1002/ped4.12320
Subject(s) - rhabdomyolysis , myalgia , medicine , creatine kinase , coronavirus , pediatrics , disease , covid-19 , infectious disease (medical specialty)
Coronavirus disease‐2019 (COVID‐19) presents with a variety of symptoms, but rhabdomyolysis has rarely been reported in children. Case presentation We report a 10‐year‐old girl who presented with fever, myalgia, and limping. The patient was tested positive for severe acute respiratory syndrome coronavirus‐2. On admission, creatine kinase (CK) level was 13 147 units per liter and the patient was diagnosed with rhabdomyolysis. She was treated with intravenous fluids, which resulted in CK levels decrease. There are currently seven case reports of children with rhabdomyolysis associated with acute COVID‐19 infection and two reports with the multisystemic inflammatory syndrome. Conclusion Children presenting with muscle pain and weakness in the acute phase or following COVID‐19 infection, should alert physicians of the possibility of rhabdomyolysis.